199 related articles for article (PubMed ID: 7766804)
1. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes.
Ueng YF; Shimada T; Yamazaki H; Guengerich FP
Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
3. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
[TBL] [Abstract][Full Text] [Related]
4. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
5. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.
Xue L; Wang HF; Wang Q; Szklarz GD; Domanski TL; Halpert JR; Correia MA
Chem Res Toxicol; 2001 May; 14(5):483-91. PubMed ID: 11368545
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.
Ramsdell HS; Parkinson A; Eddy AC; Eaton DL
Toxicol Appl Pharmacol; 1991 May; 108(3):436-47. PubMed ID: 1902334
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe.
Wang H; Dick R; Yin H; Licad-Coles E; Kroetz DL; Szklarz G; Harlow G; Halpert JR; Correia MA
Biochemistry; 1998 Sep; 37(36):12536-45. PubMed ID: 9730826
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes.
Kim BR; Oh HS; Kim DH
Biochem Mol Biol Int; 1997 Nov; 43(4):839-46. PubMed ID: 9385444
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activities.
Gillam EM; Guo Z; Ueng YF; Yamazaki H; Cock I; Reilly PE; Hooper WD; Guengerich FP
Arch Biochem Biophys; 1995 Mar; 317(2):374-84. PubMed ID: 7893152
[TBL] [Abstract][Full Text] [Related]
10. Cloning, expression and functional characterization of cytochrome P450 3A37 from turkey liver with high aflatoxin B1 epoxidation activity.
Rawal S; Yip SS; Coulombe RA
Chem Res Toxicol; 2010 Aug; 23(8):1322-9. PubMed ID: 20707407
[TBL] [Abstract][Full Text] [Related]
11. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of aflatoxin B1 by rabbit and rat nasal mucosa microsomes and purified cytochrome P450, including isoforms 2A10 and 2A11.
Putt DA; Ding X; Coon MJ; Hollenberg PF
Carcinogenesis; 1995 Jun; 16(6):1411-7. PubMed ID: 7788862
[TBL] [Abstract][Full Text] [Related]
13. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer.
Guengerich FP; Johnson WW; Ueng YF; Yamazaki H; Shimada T
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):557-62. PubMed ID: 8781383
[TBL] [Abstract][Full Text] [Related]
14. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1.
Kamdem LK; Meineke I; Gödtel-Armbrust U; Brockmöller J; Wojnowski L
Chem Res Toxicol; 2006 Apr; 19(4):577-86. PubMed ID: 16608170
[TBL] [Abstract][Full Text] [Related]
15. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic activation of aflatoxin B1 by pulmonary, renal, and hepatic cytochrome P450s from rats.
Imaoka S; Ikemoto S; Shimada T; Funae Y
Mutat Res; 1992 Oct; 269(2):231-6. PubMed ID: 1383706
[TBL] [Abstract][Full Text] [Related]
17. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
Yamazaki H; Shaw PM; Guengerich FP; Shimada T
Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
[TBL] [Abstract][Full Text] [Related]
18. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
[TBL] [Abstract][Full Text] [Related]
19. Heterologous expression of CYP2K1 and identification of the expressed protein (BV-CYP2K1) as lauric acid (omega-1)-hydroxylase and aflatoxin B1 exo-epoxidase.
Yang YH; Miranda CL; Henderson MC; Wang-Buhler JL; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1279-83. PubMed ID: 11038153
[TBL] [Abstract][Full Text] [Related]
20. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
Takahashi N; Harttig U; Williams DE; Bailey GS
Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]